Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

71.28
BATS BZX Real-Time Price
As of 10:05am ET
 +0.16 / +0.22%
Today’s Change
39.24
Today|||52-Week Range
72.73
+70.81%
Year-to-Date
No recent news for Agios Pharmaceuticals Inc.

Today’s Trading

Previous close71.12
Today’s open71.11
Day’s range70.91 - 71.33
Volume1,069
Average volume (3 months)476,186
Market cap$3.4B
Dividend yield--
Data as of 10:05am ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)-60.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+18.22%
P/E ratioNM
Price/Sales23.36
Price/Book8.37

Competitors

 Today’s
change
Today’s
% change
HCMHutchison China Medi...+0.14+0.46%
SAGESAGE Therapeutics In...+0.42+0.68%
ICPTIntercept Pharmaceut...+1.27+1.89%
LGNDLigand Pharmaceutica...+0.50+0.35%
Data as of 10:04am ET, 10/17/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.78
Annual revenue (last year)$69.9M
Annual profit (last year)-$198.5M
Net profit margin-283.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Financial Officer
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts